Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): February 14, 2008

EHEALTH, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-33071   56-2357876
(State or other jurisdiction of
incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

440 EAST MIDDLEFIELD ROAD

MOUNTAIN VIEW, CALIFORNIA 94043

(Address of principal executive offices) (Zip Code)

(650) 584-2700

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Section 2 — Financial Information

 

Item 2.02 Results of Operations and Financial Condition.

On February 14, 2008, eHealth, Inc. issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2007. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in Item 2.02 of this Current Report on Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Except as shall be expressly set forth by specific reference in such filing, the information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by eHealth, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Section 9 — Financial Statements and Exhibits

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits

 

Exhibit No.

  

Description

99.1    Press Release of eHealth, Inc. dated February 14, 2008.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 14, 2008       /s/ STUART M. HUIZINGA
        Stuart M. Huizinga
        Chief Financial Officer
        (Principal Financial and Accounting Officer)


EXHIBIT INDEX

 

Exhibit No.

  

Description

99.1    Press Release of eHealth, Inc. dated February 14, 2008.
Press Release of eHealth, Inc.

Exhibit 99.1

LOGO

eHealth, Inc. Announces Fourth Quarter and Fiscal 2007 Results

Fourth Quarter Highlights

 

   

Revenue of $24.2 million, up 39% on a year-over-year basis

 

   

Growth in submitted applications of 28% year-over-year

 

   

Operating income of $4.3 million, up 56% year-over-year

 

   

Net income of $22.4 million, or $0.86 per diluted share, including a $18.9 million income tax benefit due to the reversal of the valuation allowance against deferred tax assets

 

   

Cash flow from operations of $7.9 million, up 61% year-over-year

MOUNTAIN VIEW, Calif.—February 14, 2008— eHealth, Inc. (NASDAQ: EHTH), the leading online source of health insurance for individuals, families and small businesses, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2007.

“eHealth’s performance during the fourth quarter of 2007 illustrates progress, execution, and momentum across all important areas of our business. Among many highlights of the quarter are increased application growth and the highest operating cash flow in our company’s history,” said Gary Lauer, chief executive officer of eHealth.

Fourth Quarter Results

Revenue—Revenue totaled $24.2 million for the fourth quarter of 2007, a 39% increase compared to revenue of $17.4 million for the fourth quarter of 2006.

Membership—Estimated membership at December 31, 2007 totaled 518,400 members, a 32% increase over estimated membership at December 31, 2006.

Submitted Applications—Submitted applications for individual and family products increased 28% in the fourth quarter of 2007 to 97,900 applications, compared to 76,300 applications in the fourth quarter of 2006.

Operating Income—Operating income increased 56% to $4.3 million for the fourth quarter of 2007, compared to operating income of $2.8 million for the fourth quarter of 2006. Operating margins were 18% in the fourth quarter of 2007, up from 16% in the fourth quarter of 2006. Non-GAAP operating income increased 66% to $4.9 million for the fourth quarter of 2007, compared to non-GAAP operating income of $2.9 million for the fourth quarter of 2006. Non-GAAP operating margins were 20% in the fourth quarter of 2007, up from 17% in the fourth quarter of 2006. Non-GAAP operating income and margins in the fourth quarter of 2007 exclude $544,000 of stock-based compensation expense and non-GAAP operating income and margins in the fourth quarter of 2006 exclude $158,000 of stock-based compensation expense.

Pre-tax Income—Pre-tax income for the fourth quarter of 2007 was $5.7 million, a 54% increase compared to pre-tax income of $3.7 million for the fourth quarter of 2006. Non-GAAP pre-tax income increased to $6.3 million for the fourth quarter of 2007, compared to non-GAAP pre-tax income of $3.9 million for the fourth quarter of 2006, an increase of 62%. Non-GAAP pre-tax income in the fourth quarters of 2007 and 2006 exclude $544,000 and $158,000 of stock-based compensation expense, respectively.

Net Income—Net income for the fourth quarter of 2007, which included a benefit for income taxes of $18.9 million due to the reduction of the valuation allowance against deferred tax assets, was $22.4 million, or $0.86 per diluted share. Net income for the fourth quarter of 2006, which included a benefit for income taxes of $7.4 million due to the partial reduction of the valuation allowance against deferred tax assets, was $11.0 million, or $0.45 per share on a diluted basis. Non-GAAP net income for the fourth quarter of 2007 was $3.7 million, or


$0.14 per diluted share, compared to non-GAAP net income of $3.8 million, or $0.15 per diluted share, for the fourth quarter of 2006. Non-GAAP net income and non-GAAP net income per diluted share in the fourth quarter of 2007 exclude $544,000 of stock-based compensation expense, net of income tax effect of $262,000, and an $18.9 million income tax benefit from the reduction of the valuation allowance against deferred tax assets. Non-GAAP net income and non-GAAP net income per diluted share in the fourth quarter of 2006 exclude $158,000 of stock-based compensation expense, net of income tax effect of $2,000, and $7.4 million of income tax benefit from the reduction of the valuation allowance against deferred tax assets.

Cash Flow and Cash Balance—Cash flow from operations for the fourth quarter of 2007 was $7.9 million, compared to $4.9 million for the fourth quarter of 2006, representing an increase of 61%. Cash, cash equivalents and short-term marketable securities as of December 31, 2007 totaled $121.5 million, compared to $90.5 million as of December 31, 2006.

Fiscal 2007 Results

Revenue—Revenue totaled $87.8 million for the year ended December 31, 2007, a 43% increase compared to revenue of $61.3 million for the year ended December 31, 2006.

Operating Income—Operating income increased to $16.0 million for the year ended December 31, 2007, compared to operating income of $8.0 million for the year ended December 31, 2006. Operating margins were 18% for the year ended December 31, 2007, up from 13% for the year ended December 31, 2006.

Pre-tax Income—Pre-tax income for the year ended December 31, 2007 was $21.3 million, a 129% increase compared to pre-tax income of $9.3 million for the year ended December 31, 2006. The benefit for income taxes for the year ended December 31, 2007 was $10.3 million and the benefit for income taxes for the year ended December 31, 2006 was $7.2 million primarily due to reductions of the valuation allowance against deferred tax assets of $7.4 million and $18.9 million in the fourth quarters of 2006 and 2007, respectively.

Net Income—Net income for the year ended December 31, 2007, which included $18.9 million of income tax benefit recorded in the fourth quarter of 2007, was $31.6 million, or $1.22 per diluted share. Net income for the year ended December 31, 2006, which included $7.4 million of income tax benefit recorded in the fourth quarter of 2006, was $16.5 million, or $0.80 per share on a diluted basis.

Cash Flow—Cash flow from operations increased to $26.2 million for the year ended December 31, 2007, compared to $11.4 million for the year ended December 31, 2006, representing an increase of 130%.

Guidance

eHealth is providing guidance for the full year ending December 31, 2008 based on information currently available:

 

   

Total revenue is expected to be in the range of $114 million to $117 million

 

   

Stock-based compensation expense is expected to be in the range of $4.0 million to $5.5 million

 

   

GAAP income tax rate expected to be approximately 42%

 

   

GAAP net earnings per diluted share is expected to be in the range of $0.58 to $0.63 per share

 

   

Cash flow from operations is expected to be in the range of $33.5 million to $36.0 million

Webcast and Conference Call Information

A Webcast and conference call will be held today, Thursday, February 14, 2008 at 5:00 p.m. EST / 2:00 p.m. PST. The Webcast will be available live on the Investor Relations section on eHealth’s website at http://ir.ehealthinsurance.com. Individuals interested in listening to the conference call may do so by dialing 888-396-2298 for domestic callers and 617-847-8708 for international callers. The participant passcode is 95522387. A telephone replay will be available two hours following the conclusion of the call for a period of 30 days and can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers. The call ID for the replay is 15882627. The archived Webcast will also be available on the company’s website.


About eHealth, Inc.

eHealth, Inc. is the parent company of eHealthInsurance, the leading online source of health insurance for individuals, families and small businesses. eHealthInsurance presents complex health insurance information in an objective, user-friendly format, enabling the research, analysis, comparison and purchase of health insurance products that best meet consumers’ needs. eHealth and eHealthInsurance are registered trademarks of eHealthInsurance Services, Inc.

eHealth, Inc. was founded in 1997 and its technology was responsible for the nation’s first Internet-based sale of a health insurance policy. eHealth is headquartered in Mountain View, California. Additional information can be found on eHealth’s website, www.ehealthinsurance.com.

Forward-Looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding estimated membership and eHealth’s guidance for total revenue, stock-based compensation expense, GAAP income tax rate, GAAP net earnings per diluted share and cash flow from operations for the year ending December 31, 2008. These forward-looking statements are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made, including risks associated with continued acceptance of the Internet as a medium for the purchase of health insurance, eHealth’s ability to continue to increase its membership base and expand its relationships with health insurance carriers and marketing partners, the effectiveness of increased marketing spending, retention of eHealth’s members, increased rates of member turnover, changes in eHealth’s relationships with insurance carriers, system failures or capacity constraints, dependence upon Internet search engines to attract consumers who visit eHealth’s website, the performance, reliability and availability of eHealth’s ecommerce platform and underlying network infrastructure, the effectiveness of eHealth’s marketing and public relations efforts, exposure to online commerce security risks, reliance on marketing partners for the sale of health insurance, competition, protection of intellectual property and intellectual property rights claims, regulatory penalties and negative publicity, changes in the economy, compliance with insurance and other laws and regulations, and changes in laws and regulations. Other factors that could cause operating, financial and other results to differ are described in eHealth’s most recent Periodic Quarterly Report on Form 10-Q or Annual Report on Form 10-K filed with the Securities and Exchange Commission and available on the investor relations page of eHealth’s website at www.ehealthinsurance.com and on the Securities and Exchange Commission’s website at www.sec.gov. eHealth does not undertake any obligation to update any forward-looking statement to conform the statement to actual results or changes in expectations.

Non-GAAP Financial Information

This press release includes financial measures that are not in accordance with generally accepted accounting principles in the United States (“GAAP”). To supplement eHealth’s consolidated financial statements presented in accordance with GAAP, eHealth presents investors with certain non-GAAP financial measures, including non-GAAP operating income, non-GAAP operating margins, non-GAAP pre-tax income, non-GAAP net income and non-GAAP net income per diluted share.

 

   

Non-GAAP operating income consists of GAAP operating income excluding the effects of expensing stock-based compensation related to stock options, restricted stock and restricted stock units in accordance with SFAS 123R beginning in 2006 and amortization of deferred stock-based compensation expense in accordance with APB 25 for grants made prior to 2006.

 

   

Non-GAAP operating margins are calculated by dividing non-GAAP operating income by GAAP total revenue.

 

   

Non-GAAP pre-tax income consists of GAAP pre-tax income excluding the effects of expensing stock-based compensation.

 

   

Non-GAAP net income consists of GAAP net income excluding the effects of expensing stock-based compensation including the related income tax impact and excluding non-cash benefits for income taxes.


   

Non-GAAP net income per diluted share is calculated by dividing non-GAAP net income by GAAP weighted average diluted shares outstanding.

eHealth believes that the presentation of these non-GAAP financial measures provide important supplemental information to management and investors regarding financial and business trends relating to the company’s financial condition and results of operations. Management believes that the use of these non-GAAP financial measures provides consistency and comparability with the company’s past financial reports. Management also believes that the exclusion of the items described above provides an additional measure of the company’s operating results and facilitates comparisons of the company’s core operating performance against prior periods and business model objectives. This information is provided to investors in order to facilitate additional analyses of past, present and future operating performance and as a supplemental means to evaluate the company’s ongoing operations. Externally, the company believes that these non-GAAP financial measures continue to be useful to investors in their assessment of the company’s operating performance and valuation.

Non-GAAP operating income, non-GAAP operating margins, non-GAAP pre-tax income, non-GAAP net income and non-GAAP net income per diluted share are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures used in this press release have limitations in that they do not reflect all of the costs associated with the operations of the company’s business and do not reflect all of the income tax as determined in accordance with GAAP. As a result, you should not consider these measures in isolation or as a substitute for analysis of eHealth’s results as reported under GAAP. The company expects to continue to incur operating costs similar to the non-GAAP adjustments described above, and exclusion of these costs, and their related income tax impact, from non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent. The company compensates for these limitations by prominently disclosing GAAP operating income, GAAP pre-tax income, GAAP net income and GAAP net income per diluted share and providing investors with reconciliations from the company’s GAAP operating results to the non-GAAP financial measures for the relevant periods.

The accompanying tables provide more details on the GAAP financial measures that are most directly comparable to the non-GAAP financial measures and the related reconciliations between these financial measures.

Investor Relations Contact:

Dede Sheel

FD Ashton Partners

(415) 293-4412

dede.sheel@fdashtonpartners.com

www.fdashtonpartners.com

Media Contact:

Stuart Huizinga

Senior Vice President and Chief Financial Officer

(650) 210-3180

stuart.huizinga@ehealth.com

www.ehealthinsurance.com

(Tables to Follow)

# # #


EHEALTH, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

 

     December 31,
2006
    December 31,
2007
 
     (1)     (unaudited)  

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 90,316     $ 81,395  

Short-term marketable securities

     158       40,119  

Accounts receivable

     717       1,300  

Deferred income taxes

     2,257       13,240  

Prepaid expenses and other current assets

     1,926       2,098  
                

Total current assets

     95,374       138,152  

Property and equipment, net

     3,936       3,791  

Deferred income taxes

     5,165       4,535  

Other assets

     453       975  
                

Total assets

   $ 104,928     $ 147,453  
                

Liabilities and stockholders’ equity

    

Current liabilities:

    

Accounts payable

   $ 1,440     $ 1,495  

Accrued compensation and benefits

     3,743       4,849  

Accrued marketing expenses

     1,647       2,454  

Deferred revenue

     62       436  

Other current liabilities

     1,979       2,073  
                

Total current liabilities

     8,871       11,307  

Other non-current liabilities

     317       252  

Stockholders’ equity:

    

Common stock

     22       25  

Additional paid-in capital

     159,576       167,847  

Deferred stock-based compensation

     (254 )     (104 )

Accumulated deficit

     (63,655 )     (32,060 )

Accumulated other comprehensive income

     51       186  
                

Total stockholders’ equity

     95,740       135,894  
                

Total liabilities and stockholders’ equity

   $ 104,928     $ 147,453  
                

 

(1) The condensed consolidated balance sheet at December 31, 2006 has been derived from the audited consolidated financial statements at that date.


EHEALTH, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

 

     Three Months Ended
December 31,
    Year Ended
December 31,
 
     2006     2007     2006     2007  
     (unaudited)     (unaudited)     (2)     (unaudited)  

Revenue:

        

Commission

   $ 16,520     $ 22,016     $ 58,943     $ 81,502  

Sponsorship, licensing and other

     896       2,217       2,367       6,289  
                                

Total revenue

     17,416       24,233       61,310       87,791  

Operating costs and expenses:

        

Cost of revenue-sharing

     411       457       1,305       1,702  

Marketing and advertising (1)

     5,601       8,476       21,405       29,497  

Customer care and enrollment (1)

     2,947       3,278       10,991       12,137  

Technology and content (1)

     2,816       3,368       10,137       12,393  

General and administrative (1)

     2,880       4,348       9,482       16,046  
                                

Total operating costs and expenses

     14,655       19,927       53,320       71,775  
                                

Income from operations

     2,761       4,306       7,990       16,016  

Other income, net

     969       1,438       1,326       5,287  
                                

Income before income taxes

     3,730       5,744       9,316       21,303  

Benefit for income taxes

     (7,315 )     (16,616 )     (7,161 )     (10,292 )
                                

Net income

   $ 11,045     $ 22,360     $ 16,477     $ 31,595  
                                

Net income per share:

        

Basic – common stock

   $ 0.57     $ 0.92     $ 1.91     $ 1.37  

Basic – Class A nonvoting common stock

   $ 0.57       —       $ 1.91       —    

Diluted – common stock

   $ 0.45     $ 0.86     $ 0.80     $ 1.22  

Diluted – Class A nonvoting common stock

   $ 0.45       —       $ 0.80       —    

Net income:

        

Allocated to common stock

   $ 11,039     $ 22,360     $ 16,391     $ 31,595  

Allocated to Class A nonvoting common stock

     6       —         86       —    
                                

Net income

   $ 11,045     $ 22,360     $ 16,477     $ 31,595  
                                

Weighted-average number of shares used in per share amounts:

        

Basic – common stock

     19,535       24,424       8,590       23,092  

Basic – Class A nonvoting common stock

     10       —         45       —    

Diluted – common stock

     24,771       25,929       20,572       25,797  

Diluted – Class A nonvoting common stock

     10       —         45       —    

 

(1) Includes stock-based compensation as follows:

        

Marketing and advertising

   $ 15     $ 105     $ 47     $ 218  

Customer care and enrollment

     16       52       42       138  

Technology and content

     77       195       226       611  

General and administrative

     50       192       139       539  
                                

Total

   $ 158     $ 544     $ 454     $ 1,506  
                                

 

(2) The condensed consolidated statement of operations for the year ended December 31, 2006 has been derived from the audited consolidated financial statements for that year.


EHEALTH, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)

 

     Three Months Ended
December 31,
    Year Ended
December 31,
 
     2006     2007     2006     2007  
     (unaudited)     (unaudited)     (1)     (unaudited)  

Operating activities

        

Net income

   $ 11,045     $ 22,360     $ 16,477     $ 31,595  

Adjustments to reconcile net income to net cash provided by operating activities:

        

Deferred income taxes

     (7,422 )     (16,412 )     (7,422 )     (10,303 )

Depreciation and amortization

     409       434       1,526       1,709  

Stock-based compensation expense

     158       544       454       1,506  

Excess tax benefits from stock-based compensation expense

     —         (50 )     —         (50 )

Deferred rent

     82       (18 )     122       (40 )

Loss on disposal of property and equipment

     —         12       —         30  

Changes in operating assets and liabilities:

        

Accounts receivable

     84       (252 )     (589 )     (583 )

Prepaid expenses and other current assets

     (730 )     (195 )     (954 )     (11 )

Other assets

     (15 )     (1 )     (44 )     (524 )

Accounts payable

     11       610       209       308  

Accrued compensation and benefits

     932       1,025       740       958  

Accrued marketing expenses

     (81 )     31       620       807  

Deferred revenue

     3       159       (461 )     374  

Other current liabilities

     442       (337 )     734       416  
                                

Net cash provided by operating activities

     4,918       7,910       11,412       26,192  
                                

Investing activities

        

Purchases of property and equipment

     (509 )     (724 )     (2,248 )     (1,777 )

Proceeds from the sale of property and equipment

     —         —         —         14  

Changes in restricted investments

     (2 )     —         (5 )     —    

Purchases of short-term marketable securities

     —         (17,823 )     —         (54,343 )

Sales of short-term marketable securities

     —         6,796       —         8,952  

Maturities of short-term marketable securities

     —         4,895       —         5,483  
                                

Net cash used in investing activities

     (511 )     (6,856 )     (2,253 )     (41,671 )
                                

Financing activities

        

Proceeds from initial public offering

     74,752       —         74,752       —    

Costs incurred in connection with initial public offering

     (1,400 )     —         (3,309 )     (252 )

Net proceeds from exercise of common stock options

     37       1,525       476       6,868  

Excess tax benefits from stock-based compensation expense

     —         50       —         50  

Principal payments in connection with capital leases

     (134 )     (2 )     (206 )     (214 )
                                

Net cash provided by financing activities

     73,255       1,573       71,713       6,452  
                                

Effect of exchange rate changes on cash and cash equivalents

     13       42       29       106  
                                

Net increase (decrease) in cash and cash equivalents

     77,675       2,669       80,901       (8,921 )

Cash and cash equivalents at beginning of period

     12,641       78,726       9,415       90,316  
                                

Cash and cash equivalents at end of period

   $ 90,316     $ 81,395     $ 90,316     $ 81,395  
                                

 

(1) The condensed consolidated statement of cash flows for the year ended December 31, 2006 has been derived from the audited consolidated financial statements for that year.


EHEALTH, INC.

SUMMARY OF SELECTED METRICS

(Unaudited)

 

     Three Months Ended
December 31, 2006
    Three Months Ended
December 31, 2007
 

Key Metrics:

    

Operating cash flows (1)

   $ 4,918,000     $ 7,910,000  

IFP submitted applications (2)

     76,300       97,900  

IFP approved members (3)

     68,300       83,800  

Total approved members (4)

     97,200       118,800  

Total revenue (5)

   $ 17,416,000     $ 24,233,000  

Total revenue per estimated member for the period (6)

   $ 46.02     $ 48.00  
     As of
December 31, 2006
    As of
December 31, 2007
 

IFP estimated membership (7)

     319,000       432,700  

Total estimated membership (8)

     393,900       518,400  
     Three Months Ended
December 31, 2006
    Three Months Ended
December 31, 2007
 

Marketing and advertising expenses (9)

   $ 5,601,000     $ 8,476,000  

Marketing and advertising expenses as a percentage of total revenue (10)

     32 %     35 %

Marketing and advertising expenses excluding stock-based compensation (11)

     5,586,000       8,371,000  

Other Metrics:

    

Source of IFP submitted applications (as a percentage of total IFP applications for the period):

    

Direct (12)

     40 %     38 %

Marketing partners (13)

     33 %     34 %

Online advertising (14)

     27 %     28 %
                

Total

     100 %     100 %
                

Acquisition cost per individual on IFP submitted applications (15)

   $ 47.48     $ 56.73  

Acquisition cost (excluding stock-based compensation) per individual on IFP submitted applications (16)

   $ 47.36     $ 56.03  

Notes:

 

(1) Net cash provided by operating activities for the period from the condensed consolidated statements of cash flows.

 

(2) Individual and Family Product (“IFP”) applications submitted on eHealth’s website during the period.

 

(3) New IFP members reported to eHealth as approved during the period. Some members that are approved by a carrier do not accept the approval and therefore do not become paying members.

 

(4) New members for all products reported to eHealth as approved during the period. Some members that are approved by a carrier do not accept the approval and therefore do not become paying members.

 

(5) Total revenue recognized during the period (all sources) from the condensed consolidated statements of operations.

 

(6) Calculated as total revenue recognized during the period (see note (5)) divided by average estimated membership for the period (calculated as beginning and ending estimated membership for all products for the period, divided by two).

 

(7) Estimated number of members active on IFP insurance policies as of the date indicated.

 

(8) Estimated number of members active on all insurance policies as of the date indicated.

 

(9) Marketing and advertising expenses for the period from the condensed consolidated statements of operations.

 

(10) Calculated as marketing and advertising expenses for the period (see note (9)) divided by total revenue for the period (see note (5)).

 

(11) Marketing and advertising expenses excluding stock-based compensation for the period.

 

(12) Percentage of IFP submitted applications from applicants who came directly to the eHealth website through algorithmic search engine results or otherwise.

 

(13) Percentage of IFP submitted applications from applicants sourced through eHealth’s network of marketing partners.

 

(14) Percentage of IFP submitted applications from applicants sourced through paid search and other online advertising activities.

 

(15) Calculated as marketing and advertising expenses for the period (see note (9)) divided by the number of individuals on IFP applications completed on eHealth’s website during the period.

 

(16) Calculated as marketing and advertising expenses excluding stock-based compensation for the period (see note (11)) divided by the number of individuals on IFP applications completed on eHealth’s website during the period.


EHEALTH, INC.

GAAP TO NON-GAAP RECONCILIATION

FOR THE THREE MONTHS ENDED DECEMBER 31, 2007

(In thousands, except per share amounts, unaudited)

Statement of Operations Reconciliation

 

     Three Months Ended December 31, 2007  
     GAAP
Reported
    Adjustments     Non-GAAP
Results
   Percent of
Total
Revenue
 

Revenue:

         

Commission

   $ 22,016     $ —       $ 22,016    91 %

Sponsorship, licensing and other

     2,217       —         2,217    9  
                             

Total revenue

     24,233       —         24,233    100  

Operating costs and expenses:

         

Cost of revenue-sharing

     457       —         457    2  

Marketing and advertising (1)

     8,476       (105 )     8,371    35  

Customer care and enrollment (1)

     3,278       (52 )     3,226    13  

Technology and content (1)

     3,368       (195 )     3,173    13  

General and administrative (1)

     4,348       (192 )     4,156    17  
                             

Total operating costs and expenses

     19,927       (544 )     19,383    80  
                             

Income from operations

     4,306       544       4,850    20  

Other income, net

     1,438       —         1,438    6  
                             

Income before income taxes

     5,744       544       6,288    26  

Provision (benefit) for income taxes (2)

     (16,616 )     19,194       2,578    11  
                             

Net income

   $ 22,360     $ (18,650 )   $ 3,710    15 %
                             

Net income per share:

         

Basic – common stock

   $ 0.92     $ (0.77 )   $ 0.15   

Diluted – common stock

   $ 0.86     $ (0.72 )   $ 0.14   

Weighted-average number of shares used in per share amounts:

         

Basic – common stock

     24,424       24,424       24,424   

Diluted – common stock

     25,929       25,929       25,929   

Explanation of adjustments

 

(1) Non-GAAP results exclude the effect of expensing stock-based compensation related to stock options, restricted stock and restricted stock units in accordance with SFAS 123R beginning in 2006, in addition to the amortization of deferred stock-based compensation expense in accordance with APB 25 for grants made prior to 2006.

 

(2) In the fourth quarter of 2007, management concluded that it is more likely than not that eHealth will realize sufficient future earnings to utilize its remaining deferred tax assets. Accordingly, eHealth reduced the valuation allowance by $18.9 million against deferred tax assets resulting in a tax benefit in the fourth quarter of 2007. Additionally, non-GAAP results exclude the income tax impact of $262,000 from the stock-based compensation expense listed in item (1) above.


EHEALTH, INC.

GAAP TO NON-GAAP RECONCILIATION

FOR THE THREE MONTHS ENDED DECEMBER 31, 2006

(In thousands, except per share amounts, unaudited)

Statement of Operations Reconciliation

 

     Three Months Ended December 31, 2006  
     GAAP
Reported
    Adjustments     Non-GAAP
Results
   Percent of
Total
Revenue
 

Revenue:

         

Commission

   $ 16,520     $ —       $ 16,520    95 %

Sponsorship, licensing and other

     896       —         896    5  
                             

Total revenue

     17,416       —         17,416    100  

Operating costs and expenses:

         

Cost of revenue-sharing

     411       —         411    2  

Marketing and advertising (1)

     5,601       (15 )     5,586    32  

Customer care and enrollment (1)

     2,947       (16 )     2,931    17  

Technology and content (1)

     2,816       (77 )     2,739    16  

General and administrative (1)

     2,880       (50 )     2,830    16  
                             

Total operating costs and expenses

     14,655       (158 )     14,497    83  
                             

Income from operations

     2,761       158       2,919    17  

Other income, net

     969       —         969    5  
                             

Income before income taxes

     3,730       158       3,888    22  

Provision (benefit) for income taxes (2)

     (7,315 )     7,424       109    0  
                             

Net income

   $ 11,045     $ (7,266 )   $ 3,779    22 %
                             

Net income per share:

         

Basic – common stock

   $ 0.57     $ (0.38 )   $ 0.19   

Basic – Class A nonvoting common stock

   $ 0.57     $ (0.38 )   $ 0.19   

Diluted – common stock

   $ 0.45     $ (0.30 )   $ 0.15   

Diluted – Class A nonvoting common stock

   $ 0.45     $ (0.30 )   $ 0.15   

Net income:

         

Allocated to common stock

   $ 11,039     $ (7,262 )   $ 3,777   

Allocated to Class A nonvoting common stock

     6       (4 )     2   
                         

Net income

   $ 11,045     $ (7,266 )   $ 3,779   
                         

Weighted-average number of shares used in per share amounts:

         

Basic – common stock

     19,535       19,535       19,535   

Basic – Class A nonvoting common stock

     10       10       10   

Diluted – common stock

     24,771       24,771       24,771   

Diluted – Class A nonvoting common stock

     10       10       10   

Explanation of adjustments

 

(1) Non-GAAP results exclude the effect of expensing stock-based compensation related to stock options, restricted stock and restricted stock units in accordance with SFAS 123R beginning in 2006, in addition to the amortization of deferred stock-based compensation expense in accordance with APB 25 for grants made prior to 2006.

 

(2) In the fourth quarter of 2006, management concluded that it was more likely than not that eHealth would realize sufficient future earnings to utilize a portion of its deferred tax assets. Accordingly, eHealth reduced the valuation allowance by $7.4 million against deferred tax assets resulting in a tax benefit in the fourth quarter of 2006. Additionally, non-GAAP results exclude the income tax impact of $2,000 from the stock-based compensation expense listed in item (1) above.


EHEALTH, INC.

GAAP TO NON-GAAP RECONCILIATION

FOR THE YEAR ENDED DECEMBER 31, 2007

(In thousands, except per share amounts, unaudited)

Statement of Operations Reconciliation

 

     Year Ended December 31, 2007  
     GAAP
Reported
    Adjustments     Non-GAAP
Results
   Percent of
Total
Revenue
 

Revenue:

         

Commission

   $ 81,502     $ —       $ 81,502    93 %

Sponsorship, licensing and other

     6,289       —         6,289    7  
                             

Total revenue

     87,791       —         87,791    100  

Operating costs and expenses:

         

Cost of revenue-sharing

     1,702       —         1,702    2  

Marketing and advertising (1)

     29,497       (218 )     29,279    33  

Customer care and enrollment (1)

     12,137       (138 )     11,999    14  

Technology and content (1)

     12,393       (611 )     11,782    13  

General and administrative (1)

     16,046       (539 )     15,507    18  
                             

Total operating costs and expenses

     71,775       (1,506 )     70,269    80  
                             

Income from operations

     16,016       1,506       17,522    20  

Other income, net

     5,287       —         5,287    6  
                             

Income before income taxes

     21,303       1,506       22,809    26  

Provision (benefit) for income taxes (2)

     (10,292 )     19,256       8,964    10  
                             

Net income

   $ 31,595     $ (17,750 )   $ 13,845    16 %
                             

Net income per share:

         

Basic – common stock

   $ 1.37     $ (0.77 )   $ 0.60   

Diluted – common stock

   $ 1.22     $ (0.68 )   $ 0.54   

Weighted-average number of shares used in per share amounts:

         

Basic – common stock

     23,092       23,092       23,092   

Diluted – common stock

     25,797       25,797       25,797   

Explanation of adjustments

 

(1) Non-GAAP results exclude the effect of expensing stock-based compensation related to stock options, restricted stock and restricted stock units in accordance with SFAS 123R beginning in 2006, in addition to the amortization of deferred stock-based compensation expense in accordance with APB 25 for grants made prior to 2006.

 

(2) In the fourth quarter of 2007, management concluded that it is more likely than not that eHealth will realize sufficient future earnings to utilize its remaining deferred tax assets. Accordingly, eHealth reduced the valuation allowance by $18.9 million against deferred tax assets resulting in a tax benefit for 2007. Additionally, non-GAAP results exclude the income tax impact of $324,000 from the stock-based compensation expense listed in item (1) above.


EHEALTH, INC.

GAAP TO NON-GAAP RECONCILIATION

FOR THE YEAR ENDED DECEMBER 31, 2006

(In thousands, except per share amounts, unaudited)

Statement of Operations Reconciliation

 

     Year Ended December 31, 2006  
     GAAP
Reported
    Adjustments     Non-GAAP
Results
   Percent of
Total
Revenue
 

Revenue:

         

Commission

   $ 58,943     $ —       $ 58,943    96 %

Sponsorship, licensing and other

     2,367       —         2,367    4  
                             

Total revenue

     61,310       —         61,310    100  

Operating costs and expenses:

         

Cost of revenue-sharing

     1,305       —         1,305    2  

Marketing and advertising (1)

     21,405       (47 )     21,357    35  

Customer care and enrollment (1)

     10,991       (42 )     10,949    18  

Technology and content (1)

     10,137       (226 )     9,912    16  

General and administrative (1)

     9,482       (139 )     9,343    15  
                             

Total operating costs and expenses

     53,320       (454 )     52,866    86  
                             

Income from operations

     7,990       454       8,444    14  

Other income, net

     1,326       —         1,326    2  
                             

Income before income taxes

     9,316       454       9,770    16  

Provision (benefit) for income taxes (2)

     (7,161 )     7,432       271    1  
                             

Net income

   $ 16,477     $ (6,978 )   $ 9,499    15 %
                             

Net income per share:

         

Basic – common stock

   $ 1.91     $ (0.81 )   $ 1.10   

Basic – Class A nonvoting common stock

   $ 1.91     $ (0.81 )   $ 1.10   

Diluted – common stock

   $ 0.80     $ (0.34 )   $ 0.46   

Diluted – Class A nonvoting common stock

   $ 0.80     $ (0.34 )   $ 0.46   

Net income:

         

Allocated to common stock

   $ 16,391     $ (6,942 )   $ 9,449   

Allocated to Class A nonvoting common stock

     86       (36 )     50   
                         

Net income

   $ 16,477     $ (6,978 )   $ 9,499   
                         

Weighted-average number of shares used in per share amounts:

         

Basic – common stock

     8,590       8,590       8,590   

Basic – Class A nonvoting common stock

     45       45       45   

Diluted – common stock

     20,572       20,572       20,572   

Diluted – Class A nonvoting common stock

     45       45       45   

Explanation of adjustments

 

(1) Non-GAAP results exclude the effect of expensing stock-based compensation related to stock options, restricted stock and restricted stock units in accordance with SFAS 123R beginning in 2006, in addition to the amortization of deferred stock-based compensation expense in accordance with APB 25 for grants made prior to 2006.

 

(2) In the fourth quarter of 2006, management concluded that it was more likely than not that eHealth would realize sufficient future earnings to utilize a portion of its deferred tax assets. Accordingly, eHealth reduced the valuation allowance by $7.4 million against deferred tax assets resulting in a tax benefit for 2006. Additionally, non-GAAP results exclude the income tax impact of $10,000 from the stock-based compensation expense listed in item (1) above.